Well, virtually no cash in the bank so either the japan deal with ongoing and upfront payments HAS to eventuate or else a CR looks likely in my view. However, it's hard to know what any deal would look like without even knowing efficacy of the treatment.
My own price target was 5-7c, but am dropping to 3-4c and would look to buy in then, based on a either a funding deal or after any CR.